Jarvis, JN; Harrison, TS (2019) Reply to Rajasingham and Boulware. Clin Infect Dis, 69 (4). pp. 732-735. ISSN 1537-6591 https://doi.org/10.1093/cid/ciz040
SGUL Authors: Harrison, Thomas Stephen

PDF Accepted Version Restricted to Repository staff only until 29 January 2020. Available under License ["licenses_description_publisher" not defined]. Download (403kB)

Item Type:	Article
Additional Information:	This is a pre-copyedited, author-produced version of an article accepted for publication in Clinical Infectious Diseases following peer review. The version of record Joseph N Jarvis, Thomas S Harrison, Reply to Rajasingham and Boulware, Clinical Infectious Diseases, Volume 69, Issue 4, 15 August 2019, Pages 732–735 is available online at: https://doi.org/10.1093/cid/ciz040
Keywords:	06 Biological Sciences, 11 Medical And Health Sciences, Microbiology
SGUL Research Institute / Research Centre:	Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title:	Clin Infect Dis
ISSN:	1537-6591
Language:	eng
Dates:	Date Event 15 August 2019 Published 29 January 2019 Published Online
Publisher License:	Publisher's own licence
Projects:	Project ID Funder Funder ID UNSPECIFIED European Developing Countries Clinical Trials Partnership UNSPECIFIED UNSPECIFIED Swedish International Development Corporation http://dx.doi.org/10.13039/100004441 UNSPECIFIED Wellcome Trust http://dx.doi.org/10.13039/100004440 UNSPECIFIED Medical Research Council http://dx.doi.org/10.13039/501100000265 UNSPECIFIED UKAID Joint Global Health Trials UNSPECIFIED P30 AI 045008 National Institutes of Health http://dx.doi.org/10.13039/100000002
PubMed ID:	30698672
	Go to PubMed abstract
URI:	http://sgultest.da.ulcc.ac.uk/id/eprint/110682
Publisher's version:	https://doi.org/10.1093/cid/ciz040

Actions (login required)

Edit Item